Comparing Kaya (KAYS) & Its Competitors

Kaya (OTCMKTS:KAYS) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Kaya to similar businesses based on the strength of its institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for Kaya and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kaya	0	0	0	0	N/A
Kaya Competitors	6381	18708	44577	917	2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 78.27%. Given Kaya’s competitors higher probable upside, analysts plainly believe Kaya has less favorable growth aspects than its competitors.

Earnings and Valuation

This table compares Kaya and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Kaya	$200,000.00	$1.61 million	-1.75
Kaya Competitors	$1.68 billion	$147.25 million	-1.69

Kaya’s competitors have higher revenue and earnings than Kaya. Kaya is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Kaya has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, Kaya’s competitors have a beta of 1.10, meaning that their average share price is 10% more volatile than the S&P 500.

Institutional & Insider Ownership

44.5% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 23.5% of Kaya shares are owned by company insiders. Comparatively, 14.2% of shares of all “Pharmaceutical preparations” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Kaya and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kaya	821.43%	-9.57%	638.26%
Kaya Competitors	-2,458.79%	-294.93%	-30.61%

Summary

Kaya competitors beat Kaya on 6 of the 10 factors compared.

About Kaya

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.